Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Iran Strikes Test Market Optimism Despite NearDeal Signals Micron Milestone Dicks Earnings Release and Paxtons Primary Win Lead Trading Day Focus Retail Hiring Surge in April Belies Consumer Caution Signals Mutual Fund Returns Show Mixed Trends Amid Market Volatility XOVR ETF Down 2 YTD as SpaceX IPO Nears Trailing SP 500 Rally PAMT Q2 2025 Earnings Earnings Miss and Negative Surprise Weigh on Shares RPAY Q1 2026 Earnings EPS Beat Drives Positive Market Reaction ZETA Q1 2026 Earnings Strong EPS Beat Drives Optimism Despite Modest Stock Pullback TeraWulf Inc Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges GE Vernova Q1 2026 Earnings Strong EPS Beat Fails to Lift Shares Stock Falls 36 Dycom Industries DY Rallies 225 as Stock Tests Key Resistance Zone Ecopetrol EC Holds Ground in Quiet Session Support and Resistance Levels in Focus VGI Edges Higher as Income Seekers Eye Stability Virtus Global MultiSector Income Fund VGI Holds Near Resistance Uranium Energy Corp UEC Gains 376 as Nuclear Sentiment Strengthens Palantir Clashes with London Mayor Over Blocked 50M Met Police AI Contract VIAVI Solutions Unveils CyberFlood CF1000 400G Security Test Platform for NextGeneration Networks SpaceX and OpenAI Valuations Could Surpass Berkshire Hathaway on Trading Debut Polymarket Predicts Could a 10000 Investment in Costco Turn Into 1 Million What History Suggests European Telecoms CEO Warns of Strategic Vulnerability as US Dominance in Satellites and AI Grows LZM Q2 2024 Earnings PreRevenue Mining Developer Posts WiderThanExpected Loss Stock Edges Higher Wordle 1798 Hints Continue to Draw Audience Interest Implications for Digital Puzzle Engagement NDAQ Q1 2026 Earnings EPS Beats Estimates by 111 Revenue Not Disclosed Shares Edge Higher HEPS Q1 2026 Earnings Loss Per Share of 272 Reported Stock Gains 4 CVKD Q1 2026 Earnings Narrowing Losses and Steady Progress in Clinical Pipeline